Humana is displaying robust revenue growth and expanding margins, driven by strong demand in core markets. Read more on why ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

This was the stock's second consecutive day of losses.

New target aims to reduce emissions from investments and lending activities, aligning financial influence with operational impact. LOUISVILLE, Ky., June 24, 2025--(BUSINESS WIRE)- ...

At the insurer's investor day, Humana struck a middle ground in defending the importance of the privatized Medicare program — ...

Humana leaders asserted at the company’s investor day Monday that there’s still money to be made on Medicare Advantage ...

The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks. Learn more about HUM stock here.

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Humana, the second-largest Medicare Advantage insurer in the country, is turning to a familiar strategy to boost ...